CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$14.6B
(+22%)
Cap. Flow
+$971M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
365
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
iShares MSCI China ETF
MCHI
$7.91B
| – | – | -15,000 | Closed | -$1.16M |
|
927
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -31,722 | Closed | -$3.39M |
|